Contraception by the progesterone antagonist RU 486: a novel approach to human fertility control.
Baulieu
E E
EE
D000019:Abortifacient Agents; D000021:Abortifacient Agents, Steroidal; D000028:Abortion, Induced; D001695:Biology; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003281:Contraceptives, Postcoital; D019049:Developed Countries; D004703:Endocrine System; D005060:Europe; D005193:Family Planning Services; D005602:France; D006728:Hormones; D008565:Membrane Proteins; D010827:Physiology; D011374:Progesterone; D011372:Progestins
D000019:Abortifacient Agents; D000021:Abortifacient Agents, Steroidal; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003281:Contraceptives, Postcoital; D006728:Hormones; D008565:Membrane Proteins; D011372:Progestins; D011374:Progesterone
Abortifacient Agents; Abortion, Drug Induced; Abortion, Induced; Biology; Contraception; Contraception Research; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Postcoital; Developed Countries; Endocrine System; Europe; Family Planning; Female Contraception; Fertility Control, Postcoital; Fertility Control, Postconception; France; Hormone Receptors; Hormones; Mediterranean Countries; Membrane Proteins; Physiology; Progestational Hormones; Progesterone; Research Report; Steroid Abortifacients; Western Europe